Click for best price

Transdermal Drug Delivery Systems Market Size, Share 2023

Market Analysis and Insights: Global Transdermal Drug Delivery Systems Market

The global Transdermal Drug Delivery Systems market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transdermal Drug Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transdermal Drug Delivery Systems market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transdermal Drug Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transdermal Drug Delivery Systems market.

Global Transdermal Drug Delivery Systems Scope and Market Size

Transdermal Drug Delivery Systems market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.

Segment by Type

Fentanyl

Nitroglycerin

Estradiol

Nicotine

Other

Segment by Application

OTC

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Hisamitsu

Mylan

GSK

Novartis

Teve (Actavis)

Johnson & Johnson

Lohmann

Teikoku Seiyaku

Bayer

Novartis

Teve (Actavis)

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Transdermal Drug Delivery Systems product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Transdermal Drug Delivery Systems, with price, sales, revenue, and global market share of Transdermal Drug Delivery Systems from 2019 to 2022.

Chapter 3, the Transdermal Drug Delivery Systems competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Transdermal Drug Delivery Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Transdermal Drug Delivery Systems market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Transdermal Drug Delivery Systems.

Chapter 13, 14, and 15, to describe Transdermal Drug Delivery Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Transdermal Drug Delivery Systems Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global Transdermal Drug Delivery Systems Market Research Report 2023
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2022
Forecast Year	2030
Number of Pages	101 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Fentanyl
1.2.3 Nitroglycerin
1.2.4 Estradiol
1.2.5 Nicotine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery Systems Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 OTC
1.3.3 Rx
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery Systems Market Perspective (2018-2029)
2.2 Transdermal Drug Delivery Systems Growth Trends by Region
2.2.1 Transdermal Drug Delivery Systems Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Transdermal Drug Delivery Systems Historic Market Size by Region (2018-2023)
2.2.3 Transdermal Drug Delivery Systems Forecasted Market Size by Region (2024-2029)
2.3 Transdermal Drug Delivery Systems Market Dynamics
2.3.1 Transdermal Drug Delivery Systems Industry Trends
2.3.2 Transdermal Drug Delivery Systems Market Drivers
2.3.3 Transdermal Drug Delivery Systems Market Challenges
2.3.4 Transdermal Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery Systems Players by Revenue
3.1.1 Global Top Transdermal Drug Delivery Systems Players by Revenue (2018-2023)
3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2018-2023)
3.2 Global Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue
3.4 Global Transdermal Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Transdermal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Systems Revenue in 2022
3.5 Transdermal Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Transdermal Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Transdermal Drug Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Drug Delivery Systems Breakdown Data by Type
4.1 Global Transdermal Drug Delivery Systems Historic Market Size by Type (2018-2023)
4.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2024-2029)
5 Transdermal Drug Delivery Systems Breakdown Data by Application
5.1 Global Transdermal Drug Delivery Systems Historic Market Size by Application (2018-2023)
5.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Transdermal Drug Delivery Systems Market Size (2018-2029)
6.2 North America Transdermal Drug Delivery Systems Market Size by Country (2018-2023)
6.3 North America Transdermal Drug Delivery Systems Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Transdermal Drug Delivery Systems Market Size (2018-2029)
7.2 Europe Transdermal Drug Delivery Systems Market Size by Country (2018-2023)
7.3 Europe Transdermal Drug Delivery Systems Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size (2018-2029)
8.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Country (2018-2023)
8.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Transdermal Drug Delivery Systems Market Size (2018-2029)
9.2 Latin America Transdermal Drug Delivery Systems Market Size by Country (2018-2023)
9.3 Latin America Transdermal Drug Delivery Systems Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size (2018-2029)
10.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2018-2023)
10.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Hisamitsu
11.1.1 Hisamitsu Company Detail
11.1.2 Hisamitsu Business Overview
11.1.3 Hisamitsu Transdermal Drug Delivery Systems Introduction
11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.1.5 Hisamitsu Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Transdermal Drug Delivery Systems Introduction
11.2.4 Mylan Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.2.5 Mylan Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Transdermal Drug Delivery Systems Introduction
11.3.4 GSK Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Transdermal Drug Delivery Systems Introduction
11.4.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Teve (Actavis)
11.5.1 Teve (Actavis) Company Detail
11.5.2 Teve (Actavis) Business Overview
11.5.3 Teve (Actavis) Transdermal Drug Delivery Systems Introduction
11.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.5.5 Teve (Actavis) Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Introduction
11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Lohmann
11.7.1 Lohmann Company Detail
11.7.2 Lohmann Business Overview
11.7.3 Lohmann Transdermal Drug Delivery Systems Introduction
11.7.4 Lohmann Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.7.5 Lohmann Recent Development
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Company Detail
11.8.2 Teikoku Seiyaku Business Overview
11.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Introduction
11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.8.5 Teikoku Seiyaku Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Transdermal Drug Delivery Systems Introduction
11.9.4 Bayer Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Transdermal Drug Delivery Systems Introduction
11.10.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.10.5 Novartis Recent Development
11.11 Teve (Actavis)
11.11.1 Teve (Actavis) Company Detail
11.11.2 Teve (Actavis) Business Overview
11.11.3 Teve (Actavis) Transdermal Drug Delivery Systems Introduction
11.11.4 Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.11.5 Teve (Actavis) Recent Development
11.12 Qizheng
11.12.1 Qizheng Company Detail
11.12.2 Qizheng Business Overview
11.12.3 Qizheng Transdermal Drug Delivery Systems Introduction
11.12.4 Qizheng Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.12.5 Qizheng Recent Development
11.13 Endo
11.13.1 Endo Company Detail
11.13.2 Endo Business Overview
11.13.3 Endo Transdermal Drug Delivery Systems Introduction
11.13.4 Endo Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.13.5 Endo Recent Development
11.14 Huarun 999
11.14.1 Huarun 999 Company Detail
11.14.2 Huarun 999 Business Overview
11.14.3 Huarun 999 Transdermal Drug Delivery Systems Introduction
11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.14.5 Huarun 999 Recent Development
11.15 Haw Par
11.15.1 Haw Par Company Detail
11.15.2 Haw Par Business Overview
11.15.3 Haw Par Transdermal Drug Delivery Systems Introduction
11.15.4 Haw Par Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.15.5 Haw Par Recent Development
11.16 Nichiban
11.16.1 Nichiban Company Detail
11.16.2 Nichiban Business Overview
11.16.3 Nichiban Transdermal Drug Delivery Systems Introduction
11.16.4 Nichiban Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.16.5 Nichiban Recent Development
11.17 Mentholatum
11.17.1 Mentholatum Company Detail
11.17.2 Mentholatum Business Overview
11.17.3 Mentholatum Transdermal Drug Delivery Systems Introduction
11.17.4 Mentholatum Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.17.5 Mentholatum Recent Development
11.18 Laboratoires Genevrier
11.18.1 Laboratoires Genevrier Company Detail
11.18.2 Laboratoires Genevrier Business Overview
11.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Introduction
11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.18.5 Laboratoires Genevrier Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Fentanyl
Table 3. Key Players of Nitroglycerin
Table 4. Key Players of Estradiol
Table 5. Key Players of Nicotine
Table 6. Key Players of Other
Table 7. Global Transdermal Drug Delivery Systems Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Transdermal Drug Delivery Systems Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Transdermal Drug Delivery Systems Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Transdermal Drug Delivery Systems Market Share by Region (2018-2023)
Table 11. Global Transdermal Drug Delivery Systems Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Transdermal Drug Delivery Systems Market Share by Region (2024-2029)
Table 13. Transdermal Drug Delivery Systems Market Trends
Table 14. Transdermal Drug Delivery Systems Market Drivers
Table 15. Transdermal Drug Delivery Systems Market Challenges
Table 16. Transdermal Drug Delivery Systems Market Restraints
Table 17. Global Transdermal Drug Delivery Systems Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Transdermal Drug Delivery Systems Market Share by Players (2018-2023)
Table 19. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery Systems as of 2022)
Table 20. Ranking of Global Top Transdermal Drug Delivery Systems Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Transdermal Drug Delivery Systems Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Transdermal Drug Delivery Systems Product Solution and Service
Table 24. Date of Enter into Transdermal Drug Delivery Systems Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Transdermal Drug Delivery Systems Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2018-2023)
Table 28. Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2024-2029)
Table 30. Global Transdermal Drug Delivery Systems Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Transdermal Drug Delivery Systems Revenue Market Share by Application (2018-2023)
Table 32. Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Transdermal Drug Delivery Systems Revenue Market Share by Application (2024-2029)
Table 34. North America Transdermal Drug Delivery Systems Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Transdermal Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Transdermal Drug Delivery Systems Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Transdermal Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Transdermal Drug Delivery Systems Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Transdermal Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2018-2023) & (US$ Million)
Table 43. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 44. Hisamitsu Company Detail
Table 45. Hisamitsu Business Overview
Table 46. Hisamitsu Transdermal Drug Delivery Systems Product
Table 47. Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 48. Hisamitsu Recent Development
Table 49. Mylan Company Detail
Table 50. Mylan Business Overview
Table 51. Mylan Transdermal Drug Delivery Systems Product
Table 52. Mylan Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 53. Mylan Recent Development
Table 54. GSK Company Detail
Table 55. GSK Business Overview
Table 56. GSK Transdermal Drug Delivery Systems Product
Table 57. GSK Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 58. GSK Recent Development
Table 59. Novartis Company Detail
Table 60. Novartis Business Overview
Table 61. Novartis Transdermal Drug Delivery Systems Product
Table 62. Novartis Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Teve (Actavis) Company Detail
Table 65. Teve (Actavis) Business Overview
Table 66. Teve (Actavis) Transdermal Drug Delivery Systems Product
Table 67. Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 68. Teve (Actavis) Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Transdermal Drug Delivery Systems Product
Table 72. Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Lohmann Company Detail
Table 75. Lohmann Business Overview
Table 76. Lohmann Transdermal Drug Delivery Systems Product
Table 77. Lohmann Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 78. Lohmann Recent Development
Table 79. Teikoku Seiyaku Company Detail
Table 80. Teikoku Seiyaku Business Overview
Table 81. Teikoku Seiyaku Transdermal Drug Delivery Systems Product
Table 82. Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 83. Teikoku Seiyaku Recent Development
Table 84. Bayer Company Detail
Table 85. Bayer Business Overview
Table 86. Bayer Transdermal Drug Delivery Systems Product
Table 87. Bayer Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 88. Bayer Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Transdermal Drug Delivery Systems Product
Table 92. Novartis Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Teve (Actavis) Company Detail
Table 95. Teve (Actavis) Business Overview
Table 96. Teve (Actavis) Transdermal Drug Delivery SystemsProduct
Table 97. Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 98. Teve (Actavis) Recent Development
Table 99. Qizheng Company Detail
Table 100. Qizheng Business Overview
Table 101. Qizheng Transdermal Drug Delivery SystemsProduct
Table 102. Qizheng Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 103. Qizheng Recent Development
Table 104. Endo Company Detail
Table 105. Endo Business Overview
Table 106. Endo Transdermal Drug Delivery SystemsProduct
Table 107. Endo Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 108. Endo Recent Development
Table 109. Huarun 999 Company Detail
Table 110. Huarun 999 Business Overview
Table 111. Huarun 999 Transdermal Drug Delivery SystemsProduct
Table 112. Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 113. Huarun 999 Recent Development
Table 114. Haw Par Company Detail
Table 115. Haw Par Business Overview
Table 116. Haw Par Transdermal Drug Delivery SystemsProduct
Table 117. Haw Par Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 118. Haw Par Recent Development
Table 119. Nichiban Company Detail
Table 120. Nichiban Business Overview
Table 121. Nichiban Transdermal Drug Delivery SystemsProduct
Table 122. Nichiban Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 123. Nichiban Recent Development
Table 124. Mentholatum Company Detail
Table 125. Mentholatum Business Overview
Table 126. Mentholatum Transdermal Drug Delivery SystemsProduct
Table 127. Mentholatum Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 128. Mentholatum Recent Development
Table 129. Laboratoires Genevrier Company Detail
Table 130. Laboratoires Genevrier Business Overview
Table 131. Laboratoires Genevrier Transdermal Drug Delivery SystemsProduct
Table 132. Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 133. Laboratoires Genevrier Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transdermal Drug Delivery Systems Market Share by Type: 2022 VS 2029
Figure 2. Fentanyl Features
Figure 3. Nitroglycerin Features
Figure 4. Estradiol Features
Figure 5. Nicotine Features
Figure 6. Other Features
Figure 7. Global Transdermal Drug Delivery Systems Market Share by Application in 2022 & 2029
Figure 8. OTC Case Studies
Figure 9. Rx Case Studies
Figure 10. Transdermal Drug Delivery Systems Report Years Considered
Figure 11. Global Transdermal Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Transdermal Drug Delivery Systems Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Transdermal Drug Delivery Systems Market Share by Region: 2022 VS 2029
Figure 14. Global Transdermal Drug Delivery Systems Market Share by Players in 2022
Figure 15. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery Systems as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery Systems Revenue in 2022
Figure 17. North America Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Transdermal Drug Delivery Systems Market Share by Country (2018-2029)
Figure 19. United States Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Transdermal Drug Delivery Systems Market Share by Country (2018-2029)
Figure 23. Germany Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Transdermal Drug Delivery Systems Market Share by Region (2018-2029)
Figure 31. China Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Transdermal Drug Delivery Systems Market Share by Country (2018-2029)
Figure 39. Mexico Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Transdermal Drug Delivery Systems Market Share by Country (2018-2029)
Figure 43. Turkey Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 46. Mylan Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 47. GSK Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 49. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 51. Lohmann Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 52. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 53. Bayer Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 55. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 56. Qizheng Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 57. Endo Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 58. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 59. Haw Par Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 60. Nichiban Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 61. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 62. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $2762

Multi User Price : $4143

Enterprise Price : $5524

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Transdermal Drug Delivery Systems Market Research Report 2023